GlassScriptPhysician profile
Sarah Martin
NPI 1902298912
$31,913.87
in general payments reported to CMS, 2019-2025
30 companies · $5,497 in 2025
The $5,497 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.39 · 2020: $223 · 2021: $16K · 2022: $3,593 · 2023: $3,843 · 2024: $2,861 · 2025: $5,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,910 · Travel and Lodging: $2,216 · Consulting Fee: $1,420 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,020 · Honoraria: $571 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,909.51 |
| Travel and Lodging | $2,215.62 |
| Consulting Fee | $1,420.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,020.00 |
| Honoraria | $570.99 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17,207.10 | 2020-2025 | Axonics, Solyx Sis System, General - Therapies |
| Axonics, INC. | $7,036.15 | 2021-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $5,153.98 | 2021-2025 | Altaviva, Nuro, Interstim |
| Astellas Pharma US INC | $383.73 | 2021-2023 | Myrbetriq, Veozah |
| Urovant Sciences INC | $255.22 | 2021-2022 | |
| Coloplast Corp | $156.62 | 2022-2025 | Speedicath |
| Urogen Pharma, INC. | $156.51 | 2023-2024 | Jelmyto |
| Abbvie INC. | $139.40 | 2024-2025 | |
| Antares Pharma, INC. | $138.35 | 2021 | |
| Procept Biorobotics Corporation | $134.86 | 2024-2025 | Aquabeam System |
| Bluewind Medical | $133.68 | 2024 | Revi |
| Astrazeneca Pharmaceuticals LP | $110.44 | 2024 | Lynparza |
| Ferring Pharmaceuticals INC. | $95.88 | 2025 | Adstiladrin |
| Blue Earth Diagnostics | $90.33 | 2024 | |
| Convatec INC. | $88.24 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $77.99 | 2025 | Erleada |
| Sumitomo Pharma America, INC. | $74.35 | 2023 | Gemtesa |
| 180 Medical, INC. | $74.17 | 2021-2025 | Gentlecath, Gentlecath Glide |
| Janssen Biotech, INC. | $62.61 | 2022-2023 | |
| Pfizer INC. | $57.39 | 2019 | |
| Becton, Dickinson and Company | $46.45 | 2023 | Bard Urinary Drainage Bag |
| Merck Sharp & Dohme LLC | $45.53 | 2022-2023 | Lynparza, Keytruda |
| Tolmar, INC. | $45.49 | 2025 | |
| Contura, INC. | $42.44 | 2020 | |
| Mission Pharmacal Company | $26.66 | 2022-2023 | Uribel |
| Lemaitre Vascular, INC. | $21.41 | 2023 | Artegraft Vascular Graft |
| Coopersurgical, INC. | $19.38 | 2023 | Advincula Delineator Uterine Manipulator |
| Laborie Medical Technologies Corp. | $16.13 | 2023 | |
| Davol INC. | $13.38 | 2023 | Arista Ah Flexitip |
| Intuitive Surgical, INC. | $10.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.